InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Explore the full record of transactions filed by Cheng Andrew, Chief Executive Officer. Officer active across 2 companies, notably Akero Therapeutics, Inc.. Cumulatively, 23 disclosures have been published. Total volume traded: €4m. The latest transaction was filed on 1 March 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations23 total
277,075 shares
Common Stock
SEC:0001193125-25-312131·
277,075 shares
Common Stock
SEC:0001193125-25-312131:0·
€5,48310,000 shares@ €0.54830.1% of flow
Common Stock
SEC:0001104659-22-029521:0·
€5,47710,000 shares@ €0.54770.3% of flow
Common Stock
SEC:0001104659-22-011501·
€5,47710,000 shares@ €0.54770.1% of flow
Common Stock
SEC:0001104659-22-011501:0·
€5,41710,000 shares@ €0.54170.1% of flow
Common Stock
SEC:0001104659-22-003317:0·
€5,41710,000 shares@ €0.54170.3% of flow
Common Stock
SEC:0001104659-22-003317·
€28,65953,000 shares@ €0.54071.4% of flow
Common Stock
SEC:0001104659-22-001163·
€28,65953,000 shares@ €0.54070.7% of flow
Common Stock
SEC:0001104659-22-001163:0·
€311,98317,500 shares@ €17.827615.4% of flow
Common Stock
SEC:0001104659-21-146429·
€311,98317,500 shares@ €17.82767.7% of flow
Common Stock
SEC:0001104659-21-146429:0·
€340,50817,500 shares@ €19.457616.8% of flow
Common Stock
SEC:0001104659-21-133653·
€340,50817,500 shares@ €19.45768.4% of flow
Common Stock
SEC:0001104659-21-133653:0·
€324,44117,500 shares@ €18.539516.0% of flow
Common Stock
SEC:0001104659-21-123091·
€324,44117,500 shares@ €18.53958.0% of flow
Common Stock
SEC:0001104659-21-123091:0·
€352,01917,500 shares@ €20.115417.3% of flow
Common Stock
SEC:0001104659-21-112968·
€352,01917,500 shares@ €20.11548.7% of flow
Common Stock
SEC:0001104659-21-112968:0·
€296,29816,900 shares@ €17.532414.6% of flow
Common Stock
SEC:0001104659-21-100187·
€296,29816,900 shares@ €17.53247.3% of flow
Common Stock
SEC:0001104659-21-100187:0·
€366,06617,500 shares@ €20.91818.0% of flow
Common Stock
SEC:0001104659-21-089502·
€366,06617,500 shares@ €20.9189.0% of flow
Common Stock
SEC:0001104659-21-089502:0·
17,488 shares
Class A Common Stock
SEC:0001209191-21-033807·
17,488 shares
Class A Common Stock
SEC:0001209191-21-033807:0·
23 of 23 declarations
About Cheng Andrew
Cheng Andrew is the Chief Executive Officer of Akero Therapeutics, Inc. He oversees the company's operations and strategy.
